Topical minoxidil for androgenetic alopecia
Supported hair-growth efficacy for topical treatment.
Older formulation/trial; response varies.
Original source ↗Loading TrenasCycles…
TrenasCycles
Loading TrenasCycles…
Ancillary / hair-loss medicine
Loniten
Minoxidil can help fill out thinning scalp hair, with results taking months and continued use needed. Unlike finasteride, it encourages growth rather than reducing DHT. Topical use can irritate the scalp or cause temporary shedding and unwanted hair; tablets carry extra heart-rate and fluid-retention risks, including fluid around the heart.
Directions for the cited men's 5% topical solution. Foam, women's products and oral tablets have different instructions; continued application is needed to sustain regrowth.
Randomized topical trials support hair-growth benefit. It does not block androgen signaling or prevent follicle miniaturization from all causes.
Topical irritation/unwanted hair; oral use can cause edema, tachycardia, pericardial effusion and serious hypotension.
Health problem link: androgenetic alopecia after diagnosis; scalp response and cardiovascular assessment if oral use is considered.
Topical forms are approved for androgenetic alopecia; oral minoxidil is approved for severe refractory hypertension and hair use is off-label.
Other aliases: Loniten · Rogaine
Supported hair-growth efficacy for topical treatment.
Older formulation/trial; response varies.
Original source ↗Compared hair outcomes and adverse effects.
Oral use remains off-label and has systemic cardiovascular risk.
Original source ↗